Fact checked byChristine Klimanskis, ELS

Read more

March 02, 2023
1 min read
Save

Elita femtosecond laser system receives CE mark

Fact checked byChristine Klimanskis, ELS
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Johnson & Johnson Vision received CE mark approval for the Elita femtosecond laser system, which corrects myopia in patients with or without astigmatism through the SILK procedure, according to a press release.

SILK, which stands for smooth incision lenticule keratomileusis, is a new lenticular procedure that offers posterior and anterior surface matching without corneal folding when the lenticule is removed from the cornea, better preservation of biomechanical corneal strength, and faster nerve regeneration because fewer corneal fibers are cut, the release said.

Eye surgeon
Johnson & Johnson Vision received CE mark approval for the Elita femtosecond laser system, which corrects myopia in patients with or without astigmatism through the SILK procedure, according to a press release.
Image: Adobe Stock.

The system is indicated for up to –12 D of sphere and up to –6 D of cylinder, with the sum of sphere and cylinder between –1 D and –12 D. In addition, it is indicated for LASIK flap procedures.

It is expected to be available soon in select countries in Europe and Asia Pacific.

“The Elita system represents a generational leap in corneal refractive technology, leveraging advanced technologies and designs to deliver improvements in surgical experiences and patient outcomes,” Xiao-Yu Song, global head of R&D at Johnson & Johnson Vision, said in the release. “Early clinical results have shown promising visual outcomes and patient satisfaction data, leading us to believe that the Elita system, and the SILK procedure, has the potential to elevate the standard of care for patients with myopia.”